Advertisement

Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases

  • Fernanda P. Pons-Faudoa
  • Andrea Ballerini
  • Jason Sakamoto
  • Alessandro GrattoniEmail author
Article
  • 14 Downloads
Part of the following topical collections:
  1. Biomedical Micro-Nanotechnologies toward Translation

Abstract

Chronic diseases account for the majority of all deaths worldwide, and their prevalence is expected to escalate in the next 10 years. Because chronic disorders require long-term therapy, the healthcare system must address the needs of an increasing number of patients. The use of new drug administration routes, specifically implantable drug delivery devices, has the potential to reduce treatment-monitoring clinical visits and follow-ups with healthcare providers. Also, implantable drug delivery devices can be designed to maintain drug concentrations in the therapeutic window to achieve controlled, continuous release of therapeutics over extended periods, eliminating the risk of patient non-compliance to oral treatment. A higher local drug concentration can be achieved if the device is implanted in the affected tissue, reducing systemic adverse side effects and decreasing the challenges and discomfort of parenteral treatment. Although implantable drug delivery devices have existed for some time, interest in their therapeutic potential is growing, with a global market expected to reach over $12 billion USD by 2018. This review discusses implantable drug delivery technologies in an advanced stage of development or in clinical use and focuses on the state-of-the-art of reservoir-based implants including pumps, electromechanical systems, and polymers, sites of implantation and side effects, and deployment in developing countries.

Keywords

MEMS NEMS Non-biodegradable polymers Long-acting formulations Implants 

Notes

Acknowledgements

We thank Virginia Facciotto (virginia.facciotto @gmail.com) for the design of graphics and figures. Funding support from The Nancy Owens Breast Cancer Foundation, Center for the Advancement of Science in Space (CASIS) GA-2013-118, CASIS GA-2014-145, NIH NIAID R01 AI120749-01A1, NIH NIGMS R01 GM 127558.

Compliance with ethical standards

J.S and A.G. disclose a financial interest in NanoMedical systems, Inc. F.P.P. and A.B. disclose no competing financial interest.

References

  1. F. Alfaqawi, P.L. Lip, S. Elsherbiny, R. Chavan, A. Mitra, B. Mushtaq, Eye 31, 650 (2017)CrossRefGoogle Scholar
  2. M. Ali, A. Akin, L. Bahamondes, V. Brache, N. Habib, S. Landoulsi, D. Hubacher, Hum. Reprod. 31, 2491 (2016)CrossRefGoogle Scholar
  3. E. E. Allen, Instrument for transfusion of blood with patent 249,285. 8 November 1881.Google Scholar
  4. R.H. Allen, A.M. Kaunitz, M. Hickey, in Williams Textb. Endocrinol, 13th edn., ed. by S. Melmed, K. S. Polonsky, P. R. Larsen, H. M. Kronenberg. (Elsevier, Philadelphia, 2016), pp. 664–693Google Scholar
  5. D.R.P. Almeida, E.K. Chin, K. Mears, S.R. Russell, V.B. Mahajan, Retin. Cases Brief Rep. 9, 142 (2015)CrossRefGoogle Scholar
  6. A. Alwan, D.R. MacLean, L.M. Riley, E.T. d’Espaignet, C.D. Mathers, G.A. Stevens, D. Bettcher, Lancet 376, 1861 (2010)CrossRefGoogle Scholar
  7. W.M.K. Amoaku, S. Saker, E.A. Stewart, Eye 29, 1115 (2015)CrossRefGoogle Scholar
  8. W. Andreatta, I. Elaraoud, A. Mitra, Retin. Cases Brief Rep., 1 (2017)Google Scholar
  9. R.A. Atinga, L. Yarney, N.M. Gavu, PLoS One 13, e0193995 (2018)CrossRefGoogle Scholar
  10. L. Baert, L. Schueller, Y. Tardy, D. Macbride, G. van’t Klooster, H. Borghys, E. Clessens, G. Van Den Mooter, E. Van Gyseghem, P. Van Remoortere, Int. J. Pharm. 355, 38 (2008)CrossRefGoogle Scholar
  11. C. Bailey, U. Chakravarthy, A. Lotery, G. Menon, J. Talks, C. Bailey, A. Kamal, F. Ghanchi, C. Khan, R. Johnston, M. McKibbin, A. Varma, B. Mustaq, C. Brand, J. Talks, N. Glover, Eye 31, 1707 (2017)CrossRefGoogle Scholar
  12. R. Barlow-Evans, K. Jaffer, M. Balogun, BMJ Case Rep. bcr (2017)Google Scholar
  13. P. Barnwal, S. Das, S. Mondal, A. Ramasamy, T. Maiti, A. Saha, Ther. Adv. Psychopharmacol. 7, 119 (2017)CrossRefGoogle Scholar
  14. Bausch & Lomb, Retisert®: Surgical Procedure For Implantation (n.d.), http://www.bauschretinarx.com/Portals/50/files/baus3920-retisert-surgical-Instructions-rgb-p6.pdf. Accessed 5 Mar 2018
  15. Bayer AG Pharmaceuticals, Bayer AG Pharmaceuticals: Implant Initiative Family Planning Choices in secure long-term contraception (n.d.), http://pharma.bayer.com/en/commitment-responsibility/family-planning/implant-initiative/. Accessed 25 Feb 2018
  16. R.F. Beall, J.W. Nickerson, W.A. Kaplan, A. Attaran, PLoS One 11, e0148939 (2016)CrossRefGoogle Scholar
  17. J.M. Berg, T. Dallas, in Encycl. Microfluid. Nanofluidics, ed. by D. Li. (Springer US, Boston, 2013), pp. 1–12Google Scholar
  18. S. Bernell, S. W. Howard, Front. Public Health 4, (2016)Google Scholar
  19. T. Bertelmann, S. Schulze, Ophthalmol. Ther. 4, 51 (2015)CrossRefGoogle Scholar
  20. T. Bertelmann, Senior Physician, A. Messerschmidt-Roth, and Study Co-ordinator, Department of Ophthalmology, Philipps University, Marburg, Germany, Eur. Ophthalmic Rev. 07, 122 (2013)Google Scholar
  21. J. M. Bertolote, World Health Organization: Neurological Disorders Affect Millions Globally WHO Report (2005). http://www.who.int/mediacentre/news/releases/2007/pr04/en/. Accessed 18 June 2018
  22. G. Bhatia, M. E. Lau, K. M. Koury, P. Gulur, F1000Research (2014)Google Scholar
  23. B. Bhushan, Microelectron. Eng. 84, 387 (2007)CrossRefGoogle Scholar
  24. Bill & Melinda Gates Foundation, Bill & Melinda Gates Foundation: What We Do Family Planning Strategy Overview (n.d.). https://www.gatesfoundation.org/What-We-Do/Global-Development/Family-Planning. Accessed 25 Feb 2018
  25. R. Bolash, B. Udeh, Y. Saweris, M. Guirguis, J.E. Dalton, N. Makarova, N. Mekhail, Neuromodulation Technol. Neural Interface. 18, 150(2015)CrossRefGoogle Scholar
  26. D.S. Borkar, C. Ung, L. Sobrin, Int. Ophthalmol. Clin. 57, 193 (2017)CrossRefGoogle Scholar
  27. R.C. Bourge, A.B. Waxman, M. Gomberg-Maitland, S.M. Shapiro, J.H. Tarver, D.L. Zwicke, J.P. Feldman, M.M. Chakinala, R.P. Frantz, F. Torres, J. Cerkvenik, M. Morris, M. Thalin, L. Peterson, L.J. Rubin, Chest 150, 27 (2016)CrossRefGoogle Scholar
  28. G. Bruno, T. Geninatti, R.L. Hood, D. Fine, G. Scorrano, J. Schmulen, S. Hosali, M. Ferrari, A. Grattoni, Nanoscale 7, 5240 (2015)CrossRefGoogle Scholar
  29. G. Bruno, G. Canavese, X. Liu, C.S. Filgueira, A. Sacco, D. Demarchi, M. Ferrari, A. Grattoni, Nanoscale 8, 18718 (2016)CrossRefGoogle Scholar
  30. G. Bruno, N. Di Trani, R.L. Hood, E. Zabre, C.S. Filgueira, G. Canavese, P. Jain, Z. Smith, D. Demarchi, S. Hosali, A. Pimpinelli, M. Ferrari, A. Grattoni, Nat. Commun. 9, 1682 (2018)CrossRefGoogle Scholar
  31. M.V. Carle, T.G. Chu, D.S. Boyer, Expert Rev. Ophthalmol 9, 81 (2014)CrossRefGoogle Scholar
  32. J.A. Carter, R. Dammerman, M. Frost, J. Med. Econ. 20, 893 (2017)CrossRefGoogle Scholar
  33. P.Y. Chang, Z. Kresch, C.M. Samson, R.C. Gentile, Ocul. Immunol. Inflamm. 23, 453 (2015)CrossRefGoogle Scholar
  34. J. Chevreau, D. Krief, O. Abou Arab, M. Zitoun, A. Foulon, F. Sergent, J. Gondry, Eur. J. Obstet. Gynecol. Reprod. Biol. 224, 81 (2018)CrossRefGoogle Scholar
  35. P. Christo, M. Bottros, J. Pain Res., 615 (2014)Google Scholar
  36. W. H. Chu, T. Huen, J. K. Tu, M. Ferrari, in edited by P. L. Gourley (1997), pp. 111–122Google Scholar
  37. W.-H. Chu, R. Chin, T. Huen, M. Ferrari, J. Microelectromechanical Syst. 8, 34 (1999)CrossRefGoogle Scholar
  38. C. Y. X. Chua, P. Jain, A. Susnjar, J. Rhudy, M. Folci, A. Ballerini, A. Gilbert, S. Singh, G. Bruno, C. S. F., C. Yee, E. B. Butler, A. Grattoni, (2018a) Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer. Journal of Controlled Release 285:23-34CrossRefGoogle Scholar
  39. C.Y.X. Chua, P. Jain, A. Ballerini, G. Bruno, R.L. Hood, Manas Gupte, S. Gao, N. D. Trani, A. Susnjar, K. Shelton, L. R. Bushman, M. Folci, C. S. Filgueira, M. A. Marzinke, P. L. Anderson, M. Hu, P. Nehete, R. C. Arduino, J. K. Sastry, A.o Grattoni, (2018b) Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis. Journal of Controlled Release 286315-325Google Scholar
  40. M. Chung, C. Loudill, M. Wieler, J. Farnam, S.H. Ahn, J. Vasc. Interv. Radiol. 28, 466 (2017)CrossRefGoogle Scholar
  41. M.J. Cima, H. Lee, K. Daniel, L.M. Tanenbaum, A. Mantzavinou, K.C. Spencer, Q. Ong, J.C. Sy, J. Santini, C.M. Schoellhammer, D. Blankschtein, R.S. Langer, J. Controlled Release 190, 157 (2014)CrossRefGoogle Scholar
  42. A. Cobo, R. Sheybani, E. Meng, Adv. Healthc. Mater. 4, 969 (2015)CrossRefGoogle Scholar
  43. Codman & Shurtleff, Patient Information Booklet for Pain Management Therapy CODMAN 3000 Implantable Constant-Flow Infusion Pump (2003).Google Scholar
  44. Codman & Shurtleff, CODMAN 3000 Implantable Constant-Flow Infusion Pump: Prescribing Information (n.d.). http://www.codmanpumps.com/Products_pumps_epi.asp. Accessed 23 Apr 2018.
  45. Coherent Market Insights, Global Implantable Drug Delivery Devices Market, by Product Type (Drug Infusion Pumps, Intraocular Drug Delivery Devices, Contraceptive Drug Delivery Devices and Stents), by Technology (Biodegradable Implants and Non Bio Degradable Implants), by Application (Ophthalmology, Cardiovascular, Birth Control/Contraception and Others) and by Region - Trends and Forecast till 2025 (Coherent Market Insights, 2017), p. 144.Google Scholar
  46. M. Comlossy, Chronic Disease Prevention and Management (2013).Google Scholar
  47. J. Cunha-Vaz, P. Ashton, R. Iezzi, P. Campochiaro, P.U. Dugel, F.G. Holz, M. Weber, R.P. Danis, B.D. Kuppermann, C. Bailey, K. Billman, B. Kapik, F. Kane, K. Green, Ophthalmology 121, 1892 (2014)CrossRefGoogle Scholar
  48. R.L. Cutler, F. Fernandez-Llimos, M. Frommer, C. Benrimoj, V. Garcia-Cardenas, BMJ Open 8, e016982 (2018)CrossRefGoogle Scholar
  49. M. Danckwerts, A. Fassihi, Drug Dev. Ind. Pharm. 17, 1465 (1991)CrossRefGoogle Scholar
  50. J.S. Davis, F. Alkhoury, C. Burnweit, J. Pediatr. Surg. 49, 807 (2014)CrossRefGoogle Scholar
  51. T.R. Deer, J.E. Pope, Expert Rev. Clin. Pharmacol. 8, 507 (2015)CrossRefGoogle Scholar
  52. Delpor, Delpor Delivering the Future of Medicine: Delpor’s Device Device (n.d.-a). https://www.delpor.com/delpors-device/. Accessed 24 Feb 2018.
  53. Delpor, Delpor Delivering the Future of Medicine: Products DLP-114 (n.d.-b), https://www.delpor.com/products/dlp-114/. Accessed 24 Feb 2018.
  54. Delpor, Delpor Delivering the Future of Medicine: Products DLP-119 (n.d.-c), https://www.delpor.com/products/dlp-119/. Accessed 24 February 2018
  55. Delpor, Delpor Delivering the Future of Medicine: Products DLP-202 (n.d.-d). https://www.delpor.com/products/dlp-202/. Accessed 24 February 2018
  56. Delpor, Delpor Delivering the Future of Medicine: Products DLP-414 (n.d.-e), https://www.delpor.com/products/dlp-414/. Accessed 24 February 2018
  57. Delpor, Delpor Delivering the Future of Medicine: Technologies NANOPOR (n.d.-f). https://www.delpor.com/technologies/nanopor/ Accessed 24 February 2018
  58. Delpor, Delpor Delivering the Future of Medicine: Technologies PROZOR (n.d.-g), https://www.delpor.com/technologies/prozor/. Accessed 24 February 2018
  59. T.A. Desai, D.J. Hansford, L. Kulinsky, A.H. Nashat, G. Rasi, J. Tu, Y. Wang, M. Zhang, M. Ferrari, Biomed Microdevices 2, 11 (1999)CrossRefGoogle Scholar
  60. N. Di Trani, A. Grattoni, M. Ferrari, in (IEEE, 2017), pp. 40.6.1–40.6.4.Google Scholar
  61. N. Di Trani, P. Jain, C.Y.X. Chua, J.S. Ho, G. Bruno, A. Susnjar, F.P. Pons-Faudoa, A. Sizovs, R.L. Hood, Z.W. Smith, A. Ballerini, C.S. Filgueira, A. Grattoni, Nanomedicine 16, 1 (2019)CrossRefGoogle Scholar
  62. D. Diego, E. Tappy, J. Carugno, Contraception 95, 218 (2017)CrossRefGoogle Scholar
  63. S. Donnelly, D. Shuriff, S. Stylianos, J. Zitsman, J. Pediatr. Surg. Case Rep. 3, 523 (2015)CrossRefGoogle Scholar
  64. I. Elaraoud, W. Andreatta, A. Kidess, A. Bhatnagar, M. Tsaloumas, F. Quhill, Y. Yang, BMC Ophthalmol. 16 (2016a)Google Scholar
  65. I. Elaraoud, A. Attawan, F. Quhill, Ophthalmol. Ther. 5, 95 (2016b)CrossRefGoogle Scholar
  66. I. Elaraoud, H. Quhill, F. Quhill, Ophthalmol. Ther. 5, 105 (2016c)CrossRefGoogle Scholar
  67. I.A. El-Ghrably, A. Saad, C. Dinah, Ophthalmol. Ther. 4, 129 (2015)CrossRefGoogle Scholar
  68. I. El-Ghrably, D.H.W. Steel, M. Habib, D. Vaideanu-Collins, S. Manvikar, R.J. Hillier, Eur. J. Ophthalmol. 27, 357 (2017)CrossRefGoogle Scholar
  69. Endo Pharmaceuticals, ClinincalTrials.gov Identifier NCT01295060 (n.d.). https://clinicaltrials.gov/ct2/show/NCT01295060. Accessed 21 Sept 2018.
  70. K.D. Ethans, O.I. Schryvers, P.W. Nance, A.R. Casey, Spinal Cord 43, 214 (2005)CrossRefGoogle Scholar
  71. E. A. Eugster, in Endocr. Dev., edited by M. Cappa, S. Cianfarani, L. Ghizzoni, S. Loche, and M. Maghnie (S. Karger AG, 2015), pp. 54–59.Google Scholar
  72. M. Farina, A. Ballerini, G. Torchio, G. Rizzo, D. Demarchi, U. Thekkedath, A. Grattoni, Biomed. Microdevices 19, 42 (2017)CrossRefGoogle Scholar
  73. R. Farra, N.F. Sheppard, L. McCabe, R.M. Neer, J.M. Anderson, J.T. Santini, M.J. Cima, R. Langer, Sci. Transl. Med. 4, 122ra21 (2012)CrossRefGoogle Scholar
  74. T. Ferkol, D. Schraufnagel, Ann. Am. Thorac. Soc. 11, 404 (2014)CrossRefGoogle Scholar
  75. M. Ferrari, I. Chu, I. Desai, D. Hansford, G. Mazzoni, T. Huen, M. Zhang, MRS Proc. 414 (1995)Google Scholar
  76. S. Ferrati, D. Fine, J. You, E. De Rosa, L. Hudson, E. Zabre, S. Hosali, L. Zhang, C. Hickman, S.S. Bansal, et al., J. Control. Release 172, 1011 (2013)CrossRefGoogle Scholar
  77. S. Ferrati, E. Nicolov, E. Zabre, T. Geninatti, B.A. Shirkey, L. Hudson, S. Hosali, M. Crawley, M. Khera, G. Palapattu, A. Grattoni, J. Sex. Med. 12, 1375 (2015)CrossRefGoogle Scholar
  78. J. Figueira, J. Henriques, M. Amaro, V. Rosas, D. Alves, J. Cunha-Vaz, Ophthalmic Res. 57, 166 (2017)CrossRefGoogle Scholar
  79. C.S. Filgueira, E. Nicolov, R.L. Hood, A. Ballerini, J. Garcia-Huidobro, J.Z. Lin, D. Fraga, P. Webb, O.M. Sabek, A.O. Gaber, K.J. Phillips, A. Grattoni, Int. J. Obes. 40, 1776 (2016)CrossRefGoogle Scholar
  80. D. Fine, A. Grattoni, S. Hosali, A. Ziemys, E.D. Rosa, J. Gill, R. Medema, L. Hudson, M. Kojic, M. Milosevic, L.B. Iii, R. Goodall, M. Ferrari, X. Liu, Lab. Chip 10, 3074 (2010)CrossRefGoogle Scholar
  81. D. Fine, A. Grattoni, E. Zabre, F. Hussein, M. Ferrari, X. Liu, Lab. Chip 11, 2526 (2011)CrossRefGoogle Scholar
  82. M.M. Fisher, D. Lemay, E.A. Eugster, J. Pediatr. 164, 912 (2014)CrossRefGoogle Scholar
  83. Flowonix Medical, Flowonix: Healthcare provider MRI information (2018), http://www.flowonix.com/healthcare-provider/mri-information Accessed 18 Sept 2018
  84. Flowonix Medical Inc., Prometra® II Programmable Pump (REF 13827) For Use with Intrathecal Catheter (2017)Google Scholar
  85. Flowonix Medical, PR Newswire: Flowonix Medical, Inc. Announces First Use of Its Patient Therapy Controller (PTC™) (n.d.). https://www.prnewswire.com/news-releases/flowonix-medical-inc-announces-first-use-of-its-patient-therapy-controller-ptc-300134985.html. Accessed 23 Apr 2018
  86. C.A. Freitas-Neto, A. Maghsoudlou, S. Dhanireddy, A. Payal, S. Boonsopon, M.D. Ratwatte, C.S. Foster, Ocul. Immunol. Inflamm. 23, 425 (2015)CrossRefGoogle Scholar
  87. N. Fullman et al., The Lancet 390, 1423 (2017)CrossRefGoogle Scholar
  88. W. Fusi-Rubiano, C. Mukherjee, M. Lane, M.D. Tsaloumas, N. Glover, A. Kidess, A.K. Denniston, H.E. Palmer, A. Manna, R. Morjaria, BMC Ophthalmol. 18 (2018)Google Scholar
  89. Genetic Engineering & Biotechnology News, Genetic Engineering & Biotechnology News: Intarcia Axes 60, Halts Studies after FDA Clinical Hold (2018), https://www.genengnews.com/gen-news-highlights/intarcia-axes-60-halts-studies-after-fda-clinical-hold/81255457. Accessed 23 Apr 2018
  90. M. Gofeld, C.K. McQueen, Pain Med. 12, 607 (2011)CrossRefGoogle Scholar
  91. D.S. Goldberg, S.J. McGee, BMC Public Health 11 (2011)Google Scholar
  92. R.S. Gonçalves, C. Teixeira, P. Coelho, Case Rep. Ophthalmol. 8, 465 (2017)CrossRefGoogle Scholar
  93. D. Grady, S. Kaplan, New York Times: A lifesaving pump for cancer patients is being phased out (2018), https://www.nytimes.com/2018/04/25/health/liver-pump-cancer-medical-device.html. 13 Sept 2018
  94. A. Grattoni, E. De Rosa, S. Ferrati, Z. Wang, A. Gianesini, X. Liu, F. Hussain, R. Goodall, M. Ferrari, J. Micromech. Microeng. 19(115), 018 (2009)Google Scholar
  95. A. Grattoni, D. Fine, E. Zabre, A. Ziemys, J. Gill, Y. Mackeyev, M.A. Cheney, D.C. Danila, S. Hosali, L.J. Wilson, et al., ACS Nano 5, 9382 (2011a)CrossRefGoogle Scholar
  96. A. Grattoni, S. Parazynski, F. Hussain, Mech. Eng. Mag. Sel. Artic. 133, 23 (2011b)Google Scholar
  97. A. Grattoni, H. Shen, D. Fine, A. Ziemys, J.S. Gill, L. Hudson, S. Hosali, R. Goodall, X. Liu, M. Ferrari, Pharm. Res. 28, 292 (2011c)CrossRefGoogle Scholar
  98. A.C.R. Grayson, R.S. Shawgo, A.M. Johnson, N.T. Flynn, Y. Li, M.J. Cima, R. Langer, Proc. IEEE 92, 6 (2004)CrossRefGoogle Scholar
  99. M. Guiahi, K. Tocce, S. Teal, T. Green, P. Rochon, Contraception 90, 606 (2014)CrossRefGoogle Scholar
  100. J.-C. Gutiérrez-Hernández, S. Caffey, W. Abdallah, P. Calvillo, R. González, J. Shih, J. Brennan, J. Zimmerman, J.-C. Martínez-Camarillo, A.R. Rodriguez, R. Varma, A. Santos, G. Sánchez, M. Humayun, Transl. Vis. Sci. Technol. 3, 8 (2014)CrossRefGoogle Scholar
  101. N. Haghjou, M. Soheilian, M.J. Abdekhodaie, J Ophthalmic Vis Res 6, 317 (2011)Google Scholar
  102. A. Hawrami, H. Laviers, S. Patra, H. Zambarakji, Acta Ophthalmol. (Copenh.) 94 (2016)Google Scholar
  103. Salim M Hayek and University Hospitals Cleveland Medical Center, ClinicalTrials.gov Identifier NCT02886286 (n.d.). https://clinicaltrials.gov/ct2/show/NCT02886286 Accessed 21 September 2018.
  104. S. Herrlich, S. Spieth, S. Messner, R. Zengerle, Adv. Drug Deliv. Rev. 64, 1617 (2012)CrossRefGoogle Scholar
  105. R.L. Hood, G. Bruno, P. Jain, J. Anderson, T. Wolfe, C. Quini, J. Schmulen, X.C. Li, E.B. Butler, S. Krishnan, A. Grattoni, J. Biomed. Nanotechnol. 12, 1907 (2016)CrossRefGoogle Scholar
  106. J. Huber, Contraception 58, 85S (1998)CrossRefGoogle Scholar
  107. M. Humayun, A. Santos, J.C. Altamirano, R. Ribeiro, R. Gonzalez, A. de la Rosa, J. Shih, C. Pang, F. Jiang, P. Calvillo, J. Huculak, J. Zimmerman, S. Caffey, Transl. Vis. Sci. Technol. 3, 5 (2014)CrossRefGoogle Scholar
  108. W. Ilias, B. le Polain, E. Buchser, L. Demartini, the oPTiMa study group, Pain Pract. 8, 164 (2008)CrossRefGoogle Scholar
  109. Intarcia Therapeutics Inc., Intarcia Therapeutics: Investors & Media Press Releases (n.d.). http://www.intarcia.com/media/press-releases/2016-dec-29-intarcia-equity-financing-gates-foundation.html Accessed 25 February 2018.
  110. Intarcia Therapeutics, Intarcia Therapeutics: Pipeline & Technology (n.d.-a). http://www.intarcia.com/pipeline-technology/ Accessed 24 February 2018
  111. Intarcia Therapeutics, Intarcia Therapeutics: Pipeline & Technology HIV Prevention (n.d.-b). http://www.intarcia.com/pipeline-technology/hiv-prevention.html Accessed 24 February 2018
  112. Intarcia Therapeutics, Intarcia Therapeutics: Pipeline & Technology Pipeline (n.d.-c). http://www.intarcia.com/pipeline-technology/pipeline.html Accessed 24 February 2018
  113. INTEGRA Biosciences, INTEGRA: Peristaltic Pump - How It Works (n.d.). https://www.integra-biosciences.com/united-states/en/news/peristaltic-pump-how-it-works Accessed 18 June 2018.
  114. M. Itzoe, M. Guarnieri, Drug Des. Devel. Ther. 11, 1429 (2017)CrossRefGoogle Scholar
  115. A. V. Kalyvas, M. S. Themistocleous, N. Mpoutos, K. Themistoklis, S. Korfias, and D. Sakas, in Conf. Congr. Eur. Soc. Ster. Funct. Neurosurg. (2014).Google Scholar
  116. N. Kamaly et al., The Lancet 388, 1775 (2016)CrossRefGoogle Scholar
  117. N. J. Kassebaum et al., The Lancet 388, 1775(2016)Google Scholar
  118. R.A. Keraliya, C. Patel, P. Patel, V. Keraliya, T.G. Soni, R.C. Patel, M.M. Patel, ISRN Pharm. 2012, 1 (2012)Google Scholar
  119. V. Kini, P.M. Ho, JAMA 320, 2461 (2018)CrossRefGoogle Scholar
  120. A. Kosturakis, R. Gebhardt, Pain Physician 15, 475 (2012)Google Scholar
  121. A. Kumar and J. Pillai, In Nanostructures Eng. Cells Tissues Organs (Elsevier, 2018), pp. 473–511.Google Scholar
  122. A. Kumar, Q. Alfahad, A. Mitra, S. Elsherbiny, P.L. Lip, Eye 30, 763 (2016)CrossRefGoogle Scholar
  123. P. Laumonerie, L. Blasco, M.E. Tibbo, O. Leclair, P. Kerezoudis, E. Chantalat, P. Mansat, World Neurosurg. 111, 317 (2018)CrossRefGoogle Scholar
  124. D. Lee, BBC News: ‘Remote control’ contraceptive chip available ‘by 2018’ (2014). http://www.bbc.com/news/technology-28193720 Accessed 22 February 2018.
  125. T. Li, A.T. Evans, S. Chiravuri, R.Y. Gianchandani, Y.B. Gianchandani, Adv. Drug Deliv. Rev. 64, 1639 (2012)CrossRefGoogle Scholar
  126. S.A. Logan, C.Y. Weng, P.E. Carvounis, Int. Ophthalmol. Clin. 56, 127 (2016)CrossRefGoogle Scholar
  127. P. Maino, E. Koetsier, R.S.G.M. Perez, R. Anesth, Pain Med. 39, 434 (2014)Google Scholar
  128. W. Majeed, H. Thabit, Expert Rev. Med. Devices 15, 579 (2018)CrossRefGoogle Scholar
  129. J.M. Maloney, S.A. Uhland, B.F. Polito, N.F. Sheppard, C.M. Pelta, J.T. Santini, J. Controlled Release 109, 244 (2005)CrossRefGoogle Scholar
  130. D.F. Martin, Arch. Ophthalmol. 112, 1531 (1994)CrossRefGoogle Scholar
  131. P. Massin, A. Erginay, B. Dupas, A. Couturier, R. Tadayoni, Clin. Ophthalmol. 10, 1257 (2016)CrossRefGoogle Scholar
  132. R. Matheson, MIT News: Big step in battling bladder disease (2014). http://news.mit.edu/2014/startups-bladder-disease-medical-device-acquired-1016 Accessed 18 June 2018.
  133. C. McConville, 30, 764 (2011).Google Scholar
  134. Medtronic, Medtronic SYNCHROMED® II Programmable Pumps Implant Manual (2011).Google Scholar
  135. Medtronic, Medtronic: Healthcare Professionals SynchroMed II Drug Infusion Pump (2017). http://www.medtronic.com/us-en/healthcare-professionals/products/neurological/intrathecal-baclofen-therapy-systems/synchromed-ii.html Accessed 24 February 2018.
  136. A. Meireles, C. Goldsmith, I. El-Ghrably, A. Erginay, M. Habib, B. Pessoa, J. Coelho, T. Patel, R. Tadayoni, P. Massin, J. Atorf, A.J. Augustin, Eye 31, 684 (2017)CrossRefGoogle Scholar
  137. E. Meng, T. Hoang, Ther. Deliv. 3, 1457 (2012a)CrossRefGoogle Scholar
  138. E. Meng, T. Hoang, Adv. Drug Deliv. Rev. 64, 1628 (2012b)CrossRefGoogle Scholar
  139. Microchips Biotech, Microchips Biotech: Teva and Microchips Biotech Announce Partnership to Enhance Patient Outcomes through Digital Drug Delivery Technology (2015). http://microchipsbiotech.com/news-pr-item.php?news=10 Accessed 24 February 2018.
  140. A.C. Miracle, M.A. Fox, R.N. Ayyangar, A. Vyas, S.K. Mukherji, D.J. Quint, Am. J. Neuroradiol. 32, 1158 (2011)CrossRefGoogle Scholar
  141. E. Moisseiev, L.S. Morse, JAMA Ophthalmol. 134, 1067 (2016)CrossRefGoogle Scholar
  142. S. Mourtzoukos, Expert Rev. Ophthalmol. 12, 95 (2017)CrossRefGoogle Scholar
  143. Nano Precision Medical, Nano Precision Medical Technology: The Goldilocks Effect (n.d.-a). http://www.nanoprecisionmedical.com/technology/the-goldilocks-effect Accessed 24 February 2018.
  144. Nano Precision Medical, Nano Precision Medical Technology: NanoPortal Technology (n.d.-b). http://www.nanoprecisionmedical.com/technology/nanoportal-technology Accessed 24 February 2018.
  145. Nano Precision Medical, Nano Precision Medical Technology: NanoPortal Capsule (n.d.-c). http://www.nanoprecisionmedical.com/technology/nanoportal-capsule Accessed 24 February 2018.
  146. Newron Sweden AB, ClinicalTrials.gov Identifier NCT00866502 (n.d.). https://clinicaltrials.gov/ct2/show/NCT00866502 Accessed 21 September 2018.
  147. B.P. Nicholson, R.P. Singh, J.E. Sears, C.Y. Lowder, P.K. Kaiser, Am. J. Ophthalmol. 154, 969 (2012)CrossRefGoogle Scholar
  148. J.C. Nickel, P. Jain, N. Shore, J. Anderson, D. Giesing, H. Lee, G. Kim, K. Daniel, S. White, C. Larrivee-Elkins, J. Lekstrom-Himes, M. Cima, Sci. Transl. Med. 4, 143ra100 (2012)CrossRefGoogle Scholar
  149. E.B. Odom, D.L. Eisenberg, I.K. Fox, Contraception 96, 89 (2017)CrossRefGoogle Scholar
  150. A.B. Oung, E. Kosirog, B. Chavez, J. Brunner, J.J. Saseen, Ther. Adv. Chronic. Dis. 8, 113 (2017)CrossRefGoogle Scholar
  151. N. Pagès-Puigdemont, M.A. Mangues, M. Masip, et al., Adv. Ther. 33, 1740 (2016)CrossRefGoogle Scholar
  152. V.T. Papastavrou, H. Zambarakji, I. Dooley, H. Eleftheriadis, T.L. Jackson, Retin. Cases Brief Rep. 11, 44 (2017)CrossRefGoogle Scholar
  153. K. Park, J. Controlled Release 190, 3 (2014)CrossRefGoogle Scholar
  154. R.K. Parrish, P.A. Campochiaro, P.A. Pearson, K. Green, C.E. Traverso, FAME Study Group, Ophthalmic Surg. Lasers Imaging Retina 47, 426(2016)CrossRefGoogle Scholar
  155. G. Paul, O. Zachrisson, A. Varrone, P. Almqvist, M. Jerling, G. Lind, S. Rehncrona, B. Linderoth, H. Bjartmarz, L.L. Shafer, R. Coffey, M. Svensson, K.J. Mercer, A. Forsberg, C. Halldin, P. Svenningsson, H. Widner, J. Frisén, S. Pålhagen, A. Haegerstrand, J. Clin. Invest. 125, 1339 (2015)CrossRefGoogle Scholar
  156. C. Pedroso, I. Martins, F. Palma, and A. I. Machado, Case Rep. 2015, bcr2014206256 (2015).Google Scholar
  157. C. Perruchoud, M. Bovy, A. Durrer, M. Rosato, B. Rutschmann, J.-P. Mustaki, E. Buchser, Neuromodulation Technol. Neural Interface 15, 31 (2012)CrossRefGoogle Scholar
  158. B. Pessoa, J. Coelho, N. Correia, N. Ferreira, M. Beirão, A. Meireles, Ophthalmic Res. 59, 68 (2018)CrossRefGoogle Scholar
  159. P. Petrou, C. Koutsandrea, D. Papaconstantinou, D. Mpouritis, I. Georgalas, Drug Des. Devel. Ther., 2373 (2014)Google Scholar
  160. J.E. Pope, T.R. Deer, Pain Manag. 5, 175 (2015)CrossRefGoogle Scholar
  161. J. E. Pope and T. R. Deer, in Treat. Chronic Pain Cond., ed. By J. E. Pope and T. R. Deer (Springer New York, New York, NY, 2017), pp. 191–193.Google Scholar
  162. D. Pragout, F. Darrouzain, H. Marret, Eur. J. Obstet. Gynecol. Reprod. Biol. (2018)Google Scholar
  163. J.H. Prescott, S. Lipka, S. Baldwin, N.F. Sheppard, J.M. Maloney, J. Coppeta, B. Yomtov, M.A. Staples, J.T. Santini, Nat. Biotechnol. 24, 437 (2006)CrossRefGoogle Scholar
  164. H. Quhill, F. Quhill, Case Rep. Ophthalmol. 7, 301 (2016)CrossRefGoogle Scholar
  165. N. Rajgor, V. Bhaskar, M. Patel, Syst. Rev. Pharm. 2, 91 (2011)CrossRefGoogle Scholar
  166. R. Rauck, T. Deer, S. Rosen, G. Padda, J. Barsa, E. Dunbar, G. Dwarakanath, Neuromodulation Technol. Neural Interface 13, 102 (2010)CrossRefGoogle Scholar
  167. R. Rauck, T. Deer, S. Rosen, G. Padda, J. Barsa, E. Dunbar, G. Dwarakanath, Neuromodulation Technol. Neural Interface 16, 163 (2013)CrossRefGoogle Scholar
  168. J. Riordan, P. Murphy, Neuromodulation Technol. Neural Interface 18, 433 (2015)CrossRefGoogle Scholar
  169. C.M. Rohloff, T.R. Alessi, B. Yang, J. Dahms, J.P. Carr, S.D. Lautenbach, J. Diabetes Sci. Technol. 2, 461 (2008)CrossRefGoogle Scholar
  170. J.S. Ross, J. Bates, C. Parzynski, J. Akar, J. Curtis, N. Desai, J. Freeman, G. Gamble, R. Kuntz, S.-X. Li, D. Marinac-Dabic, F. Masoudi, S.-L. Normand, I. Ranasinghe, R. Shaw, H. Krumholz, Med. Devices Evid. Res. 10, 165 (2017)CrossRefGoogle Scholar
  171. X. Ruan, P. Couch, H. Liu, R.V. Shah, F. Wang, S. Chiravuri, Pain Physician 13, 337 (2010)Google Scholar
  172. T. Rudlang, K. Brasso, Austin J Urol 3, 1045 (2016)Google Scholar
  173. H. Saedon, A. Anand, Y. Yang, Clin. Ophthalmol. 11, 583 (2017)CrossRefGoogle Scholar
  174. B. Samb, N. Desai, S. Nishtar, S. Mendis, H. Bekedam, A. Wright, J. Hsu, A. Martiniuk, F. Celletti, K. Patel, F. Adshead, M. McKee, T. Evans, A. Alwan, C. Etienne, The Lancet 376, 1785 (2010)CrossRefGoogle Scholar
  175. J.T. Santini, M.J. Cima, R. Langer, Nature 397, 335 (1999)CrossRefGoogle Scholar
  176. J.J. Santini, A. Richards, R. Scheidt, M. Cima, R. Langer, Angewandte Chemie International Edition 39, 2396 (2000)CrossRefGoogle Scholar
  177. G. Santus, R.W. Baker, J. Controlled Release 35, 1 (1995)CrossRefGoogle Scholar
  178. M. Saulino, M. Gofeld, Neuromodulation Technol. Neural Interface 17, 696 (2014)CrossRefGoogle Scholar
  179. V. Schmit-Eilenberger, Clin. Ophthalmol., 801 (2015)Google Scholar
  180. M. Serati, G. Bogani, S. Kumar, A. Cromi, F. Ghezzi, Contraception 91, 91 (2015)CrossRefGoogle Scholar
  181. S. Sgouros, C. Charalambides, P. Matsota, I. Tsangaris, G. Kostopanagiotou, Pediatr. Neurosurg. 46, 62 (2010)CrossRefGoogle Scholar
  182. D.E. Shumer, N.J. Nokoff, N.P. Spack, Adv. Pediatr. 63, 79 (2016)CrossRefGoogle Scholar
  183. J. Sih, S.S. Bansal, S. Filipini, S. Ferrati, K. Raghuwansi, E. Zabre, E. Nicolov, D. Fine, M. Ferrari, G. Palapattu, A. Grattoni, Anal. Bioanal. Chem. 405, 1547 (2013)CrossRefGoogle Scholar
  184. L.A. Silverman, E.K. Neely, G.B. Kletter, K. Lewis, S. Chitra, O. Terleckyj, E.A. Eugster, J. Clin. Endocrinol. Metab. 100, 2354 (2015)CrossRefGoogle Scholar
  185. C. Simon, M.S. Agier, J. Béné, C. Muller, L. Vrignaud, H. Marret, A.P. Jonville-Bera, J. Gynécologie Obstétrique, Biol. Reprod. 45, 1074 (2016)Google Scholar
  186. L. Smith, J. Mosley, J. Johnson, and M. Nasri, 42, 505 (2017).Google Scholar
  187. A.I. Son, J.D. Opfermann, C. McCue, J. Ziobro, J.H. Abrahams, K. Jones, P.D. Morton, S. Ishii, C. Oluigbo, A. Krieger, J.S. Liu, K. Hashimoto-Torii, M. Torii, Sci. Rep. 7 (2017)Google Scholar
  188. Z. Steel, C. Marnane, C. Iranpour, T. Chey, J.W. Jackson, V. Patel, D. Silove, Int. J. Epidemiol. 43, 476 (2014)CrossRefGoogle Scholar
  189. I. Stetkarova, S.A. Yablon, M. Kofler, D.S. Stokic, Neurorehabil. Neural Repair 24, 609 (2010)CrossRefGoogle Scholar
  190. C.L. Stevenson, J.T. Santini, R. Langer, Adv. Drug Deliv. Rev. 64, 1590 (2012)CrossRefGoogle Scholar
  191. Y.Y. Syed, Drugs 77, 575 (2017)CrossRefGoogle Scholar
  192. Taris Biomedical LLC, ClinicalTrials.gov Identifier NCT02722538 (n.d.-a). https://clinicaltrials.gov/ct2/show/NCT02722538 Accessed 21 September 2018.
  193. Taris Biomedical LLC, ClinicalTrials.gov Identifier NCT02720367 (n.d.-b). https://clinicaltrials.gov/ct2/show/NCT02720367 Accessed 21 September 2018.
  194. Taris Biomedical LLC, ClinicalTrials.gov Identifier NCT03404791 (n.d.-c). https://clinicaltrials.gov/ct2/show/NCT03404791 Accessed 21 September 2018.
  195. Taris Biomedical LLC, Taris Biomedical: Taris Advantage (n.d.-d). http://www.tarisbiomedical.com/taris-advantage.php Accessed 24 February 2018.
  196. The Global Cancer Observatory, International Agency for Research on Cancer: All cancers fact sheet (2018). http://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf Accessed 26 October 2018.
  197. Titan Pharmaceuticals, Titan Pharmaceuticals: Pipeline (n.d.). https://www.titanpharm.com/pipeline/overview Accessed 25 February 2018.
  198. U.S. Food and Drug Administration, U.S. Food and Drug Administration: Class 2 Device Recall Prometra II Programmable Infusion PumpPump (2018). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=156065 Accessed 23 April 2018.
  199. D. Veritti, V. Sarao, L. Diplotti, F. Samassa, P. Lanzetta, Expert Opin. Pharmacother. 18, 1507 (2017)CrossRefGoogle Scholar
  200. T. Vos et al., The Lancet 386, 743 (2015)CrossRefGoogle Scholar
  201. J. Wang, A. Jiang, M. Joshi, J. Christoforidis, Hindawi Publ. Corp. 2013, 1 (2013)Google Scholar
  202. J.T. Watson, Sci. Transl. Med. 4, 122ed1 (2012)CrossRefGoogle Scholar
  203. D. Wilkes, J. Pain Res., 571 (2014)Google Scholar
  204. W.L. Winters, Methodist DeBakey Cardiovasc. J. 11, 5 (2015)CrossRefGoogle Scholar
  205. S. Woolen, C. Holzmeyer, E. Nesbitt, P.F. Siami, Prostate Cancer 2014, 1 (2014)CrossRefGoogle Scholar
  206. World Economic Forum and Harvard School of Public Health, Methodological Appendix: The Global Economic Burden of Non-Communicable Diseases (2011).Google Scholar
  207. World Health Organization, Adherence to Long-Term Therapies: Evidence for Action (2003).Google Scholar
  208. World Health Organization, Global Report on Diabetes (WHO Press, World Health Organization, Geneva, 2016)Google Scholar
  209. World Health Organization, World Health Organization Metrics: Disability-Adjusted Life Year (DALY) (n.d.). http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/ Accessed 18 September 2018.
  210. C. Wright, J. Hall, Drug Des. Devel. Ther., 1543 (2016)Google Scholar
  211. W.-W. Yang, E. Pierstorff, J. Lab. Autom. 17, 50 (2012)CrossRefGoogle Scholar
  212. Y. Yang, C. Bailey, F.G. Holz, N. Eter, M. Weber, C. Baker, S. Kiss, U. Menchini, J.M. Ruiz Moreno, P. Dugel, A. Lotery, Eye 29, 1173 (2015)CrossRefGoogle Scholar
  213. M.N. Yasin, D. Svirskis, A. Seyfoddin, I.D. Rupenthal, J. Controlled Release 196, 208 (2014)CrossRefGoogle Scholar
  214. Y.H. Yun, B.K. Lee, K. Park, J. Controlled Release 219, 2 (2015)CrossRefGoogle Scholar
  215. A. Ziemys, A. Grattoni, D. Fine, F. Hussain, M. Ferrari, J. Phys. Chem. B 114(11), 117 (2010)Google Scholar
  216. A. Ziemys, M. Kojic, M. Milosevic, N. Kojic, F. Hussain, M. Ferrari, A. Grattoni, J. Comput. Phys. 230, 5722 (2011)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Fernanda P. Pons-Faudoa
    • 1
    • 2
  • Andrea Ballerini
    • 1
    • 3
  • Jason Sakamoto
    • 1
  • Alessandro Grattoni
    • 1
    • 4
    • 5
    Email author
  1. 1.Department of NanomedicineHouston Methodist Research InstituteHoustonUSA
  2. 2.School of Medicine and Health SciencesTecnologico de MonterreyMonterreyMexico
  3. 3.Department of Oncology and Onco-HematologyUniversity of MilanMilanItaly
  4. 4.Department of SurgeryHouston Methodist HospitalHoustonUSA
  5. 5.Department of Radiation OncologyHouston Methodist HospitalHoustonUSA

Personalised recommendations